{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:49:58Z","timestamp":1733982598927,"version":"3.30.2"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Serous tubal intraepithelial carcinoma (STIC) is regarded as the origin of most high-grade serous carcinomas (HGSC). After a diagnosis of isolated STIC, risk of developing HGSC is substantial. Since surveillance cannot detect HGSC in time to cure the disease, there is no consensus on the optimal treatment after a diagnosis of isolated STIC, but chemotherapy is considered one of the possible strategies. In this case report, we describe 2 women with advanced-stage HGSC treated with 3 cycles of neoadjuvant chemotherapy followed by interval debulking surgery. In both women, histopathological examination showed a complete histopathological tumor response, but a vital STIC was found in both cases. The 2 cases presented here indicate that STICs may not respond to chemotherapy. Further research focused on the underlying biology and chemosensitivity of STIC, as well as the effectiveness of treatment to prevent HGSC in case of isolated STIC, is needed.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001045","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T05:26:09Z","timestamp":1724390769000},"page":"94-97","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serous Tubal Intraepithelial Carcinoma After Neoadjuvant Chemotherapy: A Report of 2 Cases"],"prefix":"10.1097","volume":"44","author":[{"given":"Iris A.S.","family":"Stroot","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology"},{"name":"Department of Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Smit","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[{"name":"Department of Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marise M.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Jalving","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9on C.L.T.","family":"van Kempen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands"},{"name":"Department of Pathology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Bart","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J.E.","family":"Mourits","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"R1-20241211","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: A systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J Clin Oncol"},{"key":"R2-20241211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am J Pathol"},{"key":"R3-20241211","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PGP.0b013e3182a142c2","article-title":"Evaluation of the fallopian tubes after neoadjuvant chemotherapy: persistence of serous tubal intraepithelial carcinoma","volume":"33","author":"Colon","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20241211","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12282-009-0161-5","article-title":"Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis","volume":"17","author":"Nishimura","year":"2010","journal-title":"Breast Cancer"},{"key":"R5-20241211","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R6-20241211","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R7-20241211","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2020.02.006","article-title":"Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience","volume":"157","author":"Rush","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R8-20241211","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T19:36:49Z","timestamp":1733945809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001045","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"type":"print","value":"0277-1691"},{"type":"electronic","value":"1538-7151"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}